| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |